2023
Myelodysplastic Syndromes/Neoplasms—Insights Into Pathogenesis Leading to Improved Classification, Risk Stratification, and Treatments
Rose M, Zeidan A. Myelodysplastic Syndromes/Neoplasms—Insights Into Pathogenesis Leading to Improved Classification, Risk Stratification, and Treatments. The Cancer Journal 2023, 29: 109-110. PMID: 37195765, DOI: 10.1097/ppo.0000000000000663.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Deininger M, Shah N, Altman J, Berman E, Bhatia R, Bhatnagar B, DeAngelo D, Gotlib J, Hobbs G, Maness L, Mead M, Metheny L, Mohan S, Moore J, Naqvi K, Oehler V, Pallera A, Patnaik M, Pratz K, Pusic I, Rose M, Smith B, Snyder D, Sweet K, Talpaz M, Thompson J, Yang D, Gregory K, Sundar H. Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2020, 18: 1385-1415. PMID: 33022644, DOI: 10.6004/jnccn.2020.0047.Peer-Reviewed Original Research